Professor Steve Archibald S.J.Archibald@hull.ac.uk
Professor in Molecular Imaging
HPLC purification of GMP PET radiopharmaceuticals in the Molecular Imaging Research Centre (MIRC)
People Involved
Dr Louis Allott
Project Description
Nuclear medicine is a clinical discipline where the unique properties of ionising radiation are harnessed to diagnose and treat diseases like cancer. Positron Emission Tomography (PET) is a medical scan used in nuclear medicine, where a radioactive molecule known as a radiopharmaceutical (or radiotracer/radioligand) is traced around the body; this can be used to give insight into the biological mechanisms driving the progression of a patient’s disease. This unique feature of PET differs from other scans like X-ray, MRI and CT, which give anatomical information like the structure and shape of tumours in the body. Armed with a greater understanding of a patient’s disease, doctors can not only understand the way the body functions but also personalize and tailor their treatment regimen for maximum effect and fewer side-effects. Radiopharmaceuticals have an incredibly short shelf-life owed to the short radioactive half-life of radioisotopes used in nuclear medicine; therefore, unlike traditional pharmaceuticals which can be manufactured, distributed, and stored for month to years, radiopharmaceuticals are produced on demand, the same day as the patients scan.
| Status | Project Complete |
|---|---|
| Value | £50,000.00 |
| Project Dates | Mar 1, 2022 - Feb 28, 2023 |
You might also like
TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Dec 31, 2026
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe...
Read More about TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research.
Translational Research in the Molecular Imaging Research Centre Aug 1, 2016 - Jul 31, 2018
New technology to improve capability for clinical radiopharmaceutical production Jan 1, 2019 - Feb 28, 2022
Medical imaging techniques rely on radioactive atoms that don't last for a long time and so methods need to be developed to handle them on hospital sites or close by. Essentially this is drug factory near to the patient as the material is decaying al...
Read More about New technology to improve capability for clinical radiopharmaceutical production.
Positron Emission Tomography research Mar 1, 2016 - Feb 28, 2017
Training scientists to develop and Image materials for Tissue Engineering and Regenerative Medicine (iTERM) Oct 1, 2013 - Sep 30, 2017
With an increasingly aging population, new treatment solutions for diseased, defective, or damaged tissues need to be developed. Although human donor material would be preferable for these purposes, this is often not available and often associated wi...
Read More about Training scientists to develop and Image materials for Tissue Engineering and Regenerative Medicine (iTERM).